A Study Assessing Rocatinlimab in Combination With Topical Corticosteroid and/or Topical Calcineurin Inhibitors in Adult Participants With Moderate-to-severe Atopic Dermatitis (AD)

NCT ID: NCT05724199

Last Updated: 2025-11-24

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE3

Total Enrollment

746 participants

Study Classification

INTERVENTIONAL

Study Start Date

2023-02-21

Study Completion Date

2024-12-04

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The coprimary objectives of the study are to:

* evaluate the efficacy of rocatinlimab in combination with topical corticosteroid and/or topical calcineurin inhibitor (TCS/TCI), compared with placebo in combination with TCS/TCI at Week 24, assessed using Validated Investigator's Global Assessment for Atopic Dermatitis (vIGA-AD™).
* evaluate the efficacy of rocatinlimab, in combination with TCS/TCI, compared with placebo in combination with TCS/TCI at Week 24, assessed using Eczema Area and Severity Index (EASI).

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Atopic Dermatitis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

SEQUENTIAL

Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Participants Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Rocatinlimab Dose 1 + TCS/TCI

Rocatinlimab Dose 1 every 4 weeks (Q4W) for 24 weeks + TCS/TCI + loading dose at Week 2.

Group Type EXPERIMENTAL

Rocatinlimab

Intervention Type DRUG

Subcutaneous (SC) injection

Rocatinlimab Dose 2 + TCS/TCI

Rocatinlimab Dose 2 Q4W for 24 weeks + TCS/TCI + loading dose at Week 2.

Group Type EXPERIMENTAL

Rocatinlimab

Intervention Type DRUG

Subcutaneous (SC) injection

Placebo + TCS/TCI

Placebo Q4W for 24 weeks + TCS/TCI + loading dose at Week 2.

Group Type PLACEBO_COMPARATOR

Placebo

Intervention Type OTHER

SC injection

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Rocatinlimab

Subcutaneous (SC) injection

Intervention Type DRUG

Placebo

SC injection

Intervention Type OTHER

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

AMG 451

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age ≥ 18 years with a diagnosis of AD according to the AAD (American Academy of Dermatology) Consensus Criteria (2014) present for at least 12 months
* History of inadequate response to TCS of medium or higher potency (with or without TCI)
* EASI score ≥16
* vIGA-AD score ≥3
* ≥10% body surface area (BSA) of AD involvement
* Worst pruritus numerical rating scale ≥ 4

Exclusion Criteria

* Treatment with a biological product within 12 weeks or 5 half-lives, whichever is longer, prior to Day 1
* Treatment with any of the following medications or therapies within 4 weeks or 5 half-lives, whichever is longer, prior to Day 1:

* Systemic corticosteroids
* Nonbiologic, non-targeted Systemic immunosuppressants
* Phototherapy
* Janus kinase inhibitors
* Treatment with any of the following medications or therapies within 1 week, prior to Day 1:

* TCS
* TCI
* Topical phosphodiesterase type 4 inhibitors
* Other topical immunosuppressive agents
* Combination topical agents including TCS of any potency or TCI, PDE4 inhibitors, or other topical immunosuppressive agents
Minimum Eligible Age

18 Years

Maximum Eligible Age

100 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Amgen

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

MD

Role: STUDY_DIRECTOR

Amgen

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

The University of Alabama at Birmingham

Birmingham, Alabama, United States

Site Status

Medical Dermatology Specialists

Phoenix, Arizona, United States

Site Status

Southwest Skin Specialists

Phoenix, Arizona, United States

Site Status

US Dermatology Partners Sun City West

Sun City West, Arizona, United States

Site Status

Arkansas Research Trials, LLC

North Little Rock, Arkansas, United States

Site Status

Kern Research Inc

Bakersfield, California, United States

Site Status

Keck Medicine of University of Southern California

Los Angeles, California, United States

Site Status

Wallace Medical Group Inc

Los Angeles, California, United States

Site Status

Antelope Valley Clinical Trials

Palmdale, California, United States

Site Status

University of California at Davis Medical Center

Sacramento, California, United States

Site Status

Kaiser Permanente South Sacramento Medical Center

Sacramento, California, United States

Site Status

Acclaim Clinical Research

San Diego, California, United States

Site Status

Kaiser Permanente Medical Center - Oakland

San Francisco, California, United States

Site Status

Kaiser Permanente Medical Center - San Francisco

San Francisco, California, United States

Site Status

Synergy Dermatology

San Francisco, California, United States

Site Status

TrueBlue Clinical Research

Tampa, Florida, United States

Site Status

Olympian Clinical Research - Tampa

Tampa, Florida, United States

Site Status

Atlanta Dermatology, Vein and Research Center, PC

Alpharetta, Georgia, United States

Site Status

Divine Dermatology and Aesthetics

Atlanta, Georgia, United States

Site Status

NorthShore University HealthSystem

Skokie, Illinois, United States

Site Status

DS Research

Clarksville, Indiana, United States

Site Status

Dawes Fretzin Clinical Research Group, LLC

Indianapolis, Indiana, United States

Site Status

Dermatology and Skin Cancer Center Leawood

Leawood, Kansas, United States

Site Status

Industrial Medicine Associates Clinical Research Advanced Dermatology Care

Monroe, Louisiana, United States

Site Status

Aesthetic and Dermatology Center

Rockville, Maryland, United States

Site Status

University of Michigan Medical Center

Ann Arbor, Michigan, United States

Site Status

Oakland Hills Dermatology

Auburn Hills, Michigan, United States

Site Status

Somnos Clinical Research

Lincoln, Nebraska, United States

Site Status

Skin Specialists PC

Omaha, Nebraska, United States

Site Status

Vivida Dermatology

Las Vegas, Nevada, United States

Site Status

Las Vegas Clinical Trials

North Las Vegas, Nevada, United States

Site Status

Schweiger Dermatology Group, PC Research Division

Hackensack, New Jersey, United States

Site Status

Albuquerque Clinical Trials Incorporated

Albuquerque, New Mexico, United States

Site Status

Chear Center LLC

The Bronx, New York, United States

Site Status

Accellacare of Wilmington

Wilmington, North Carolina, United States

Site Status

Bexley Dermatology Research

Bexley, Ohio, United States

Site Status

Velocity Clinical Research Inc

Medford, Oregon, United States

Site Status

Paddington Testing Company Inc

Philadelphia, Pennsylvania, United States

Site Status

University of Pittsburgh Medical Center

Pittsburgh, Pennsylvania, United States

Site Status

Health Concepts

Rapid City, South Dakota, United States

Site Status

US Dermatology Partners Jollyville

Austin, Texas, United States

Site Status

Newco 3A Research LLC

El Paso, Texas, United States

Site Status

Sante Clinical Research

Kerrville, Texas, United States

Site Status

Texas Dermatology Research Center

Plano, Texas, United States

Site Status

Virginia Dermatology and Skin Cancer Center

Norfolk, Virginia, United States

Site Status

Cinme - Centro de Investigaciones Metabolicas

CABA, Buenos Aires, Argentina

Site Status

Framingham Centro Medico

La Plata, Buenos Aires, Argentina

Site Status

Dim Clinica Privada

Ramos Mejía, Buenos Aires, Argentina

Site Status

Buenos Aires Skin SA

Buenos Aires, Distrito Federal, Argentina

Site Status

Fundacion Cidea

Buenos Aires, Distrito Federal, Argentina

Site Status

Care- Centro de Alergia y Enfermedades Respiratorias

Buenos Aires, Distrito Federal, Argentina

Site Status

Psoriahue Medicina Interdisciplinaria SRL

Buenos Aires, Distrito Federal, Argentina

Site Status

Centro de Investigaciones Clinicas Instituto Especialidades De La Salud De Rosario

Rosario, Santa Fe Province, Argentina

Site Status

Emeritus Research Sydney

Botany, New South Wales, Australia

Site Status

Westmead Hospital

Westmead, New South Wales, Australia

Site Status

The Skin Centre

Benowa, Queensland, Australia

Site Status

Princess Alexandra Hospital

South Brisbane, Queensland, Australia

Site Status

Veracity Clinical Research

Woolloongabba, Queensland, Australia

Site Status

Emeritus Research Melbourne

Camberwell, Victoria, Australia

Site Status

Medizinische Universitaet Graz

Graz, , Austria

Site Status

Medizinische Universitaet Innsbruck

Innsbruck, , Austria

Site Status

Landeskrankenhaus Salzburg

Salzburg, , Austria

Site Status

Klinik Landstrasse

Vienna, , Austria

Site Status

Klinik Hietzing

Vienna, , Austria

Site Status

Algemeen Ziekenhuis Sint-Jan Brugge-Oostende

Bruges, , Belgium

Site Status

Centre Hospitalier Universitaire Brugmann

Brussels, , Belgium

Site Status

Universitair Ziekenhuis Brussel

Brussels, , Belgium

Site Status

Universite Catholique de Louvain Cliniques Universitaires Saint Luc

Brussels, , Belgium

Site Status

Universitair Ziekenhuis Gent

Ghent, , Belgium

Site Status

Clinique Andre Renard

Herstal, , Belgium

Site Status

Dermatologie Handelskaai

Kortrijk, , Belgium

Site Status

Universitaire Ziekenhuizen Leuven Gasthuisberg

Leuven, , Belgium

Site Status

Centre Hospitalier Universitaire de Liege - Sart Tilman

Liège, , Belgium

Site Status

Grand Hopital de Charleroi

Loverval, , Belgium

Site Status

Medical Center Asklepii OOD

Dupnitsa, , Bulgaria

Site Status

Medical Center Medconsult Pleven OOD

Pleven, , Bulgaria

Site Status

Medical Center Excelsior OOD

Sofia, , Bulgaria

Site Status

Diagnostic-Consultative Center Alexandrovska EOOD

Sofia, , Bulgaria

Site Status

Diagnostic-Consultative Center - Fokus-5 - Medical Institution for Outpatient Care OOD

Sofia, , Bulgaria

Site Status

Dermatology Research Institute Incorporated

Calgary, Alberta, Canada

Site Status

Laser Rejuvenation Clinics Edmonton D T Incorporated

Edmonton, Alberta, Canada

Site Status

Alberta Derma Surgery Centre

Edmonton, Alberta, Canada

Site Status

Enverus Medical Research

Surrey, British Columbia, Canada

Site Status

Wiseman Dermatology Research Incorporated

Winnipeg, Manitoba, Canada

Site Status

SKiN Health

Coburg, Ontario, Canada

Site Status

Centricity Research London

London, Ontario, Canada

Site Status

Dr SK Siddha Medicine Professional Corporation

Newmarket, Ontario, Canada

Site Status

Allergy Research Canada Incorporated

Niagara Falls, Ontario, Canada

Site Status

North Bay Dermatology Centre

North Bay, Ontario, Canada

Site Status

Dermatology Ottawa Research Centre

Ottawa, Ontario, Canada

Site Status

JRB Research Incorporated

Ottawa, Ontario, Canada

Site Status

The Centre for Dermatology

Richmond Hill, Ontario, Canada

Site Status

North York Research Incorporated

Toronto, Ontario, Canada

Site Status

Toronto Research Centre Inc

Toronto, Ontario, Canada

Site Status

Alliance Clinical Trials

Waterloo, Ontario, Canada

Site Status

Clinique de Dermatologie Rosemont

Montreal, Quebec, Canada

Site Status

Innovaderm Research Inc

Montreal, Quebec, Canada

Site Status

DIEX Recherche Quebec

Québec, Quebec, Canada

Site Status

Centre de Recherche Saint-Louis

Québec, Quebec, Canada

Site Status

Saskatoon Dermatology Centre

Saskatoon, Saskatchewan, Canada

Site Status

Beijing Friendship Hospital, Capital Medical University

Beijing, Beijing Municipality, China

Site Status

Peking University Third Hospital

Beijing, Beijing Municipality, China

Site Status

The First Affiliated Hospital of Fujian Medical University

Fuzhou, Fujian, China

Site Status

The First Affiliated Hospital ,Sun-Yat Sen University

Guangzhou, Guangdong, China

Site Status

Dermatology Hospital of Southern Medical University

Guangzhou, Guangdong, China

Site Status

Sun Yat-sen Memorial Hospital Sun Yat-sen University

Guangzhou, Guangdong, China

Site Status

The Fist Affiliated Hospital of Shantou University Medical College

Shantou, Guangdong, China

Site Status

Shenzhen Qianhai Shekou Free Trade Zone Hospital

Shenzhen, Guangdong, China

Site Status

Nanyang First Peoples Hospital

Nanyang, Henan, China

Site Status

Union Hospital Tongji Medical College Huazhong University of science and Technology

Wuhan, Hubei, China

Site Status

Wuxi Second Peoples Hospital

Wuxi, Jiangsu, China

Site Status

Dermatology Hospital of Jiangxi Province

Nanchang, Jiangxi, China

Site Status

The First Hospital of Jilin University

Changchun, Jilin, China

Site Status

Chengdu Second Peoples Hospital

Chengdu, Sichuan, China

Site Status

the First Affiliated Hospital Zhejiang University School of Medicine

Hangzhou, Zhejiang, China

Site Status

Sir Run Run Shaw Hospital Affiliated to Zhejiang University School of Medicine

Hangzhou, Zhejiang, China

Site Status

Affiliated Hangzhou First Peoples Hospital,Zhejiang University School of Medicine

Hangzhou, Zhejiang, China

Site Status

The First Affiliation Hospital Of Ningbo University

Ningbo, Zhejiang, China

Site Status

Taizhou Central Hospital

Taizhou, Zhejiang, China

Site Status

Peking University Peoples Hospital

Beijing, , China

Site Status

Shanghai Skin Disease Hospital

Shanghai, , China

Site Status

Hopital Prive d Antony

Antony, , France

Site Status

Centre Hospitalier Universitaire de Bordeaux - Hôpital Saint André

Bordeaux, , France

Site Status

Centre Hospitalier Regional Universitaire Brest Hopital Morvan

Brest, , France

Site Status

Centre Hospitalier Régional Universitaire de Lille - Hôpital Claude Huriez

Lille, , France

Site Status

Centre Hospitalier de Bretagne Sud - Hopital du Scorff

Lorient, , France

Site Status

Hôpital La Timone

Marseille, , France

Site Status

Cabinet du Docteur Ruer-Mulard Mireille

Martigues, , France

Site Status

Centre Hospitalier Universitaire de Nantes Hôtel Dieu

Nantes, , France

Site Status

Centre Hospitalier Universitaire Archet 2

Nice, , France

Site Status

Hopital Bichat Claude Bernard

Paris, , France

Site Status

Hopital Tenon

Paris, , France

Site Status

Hopital Saint Louis

Paris, , France

Site Status

Polyclinique de Courlancy

Reims, , France

Site Status

Centre Hospitalier Universitaire de Rennes - Hopital Pontchaillou

Rennes, , France

Site Status

Centre Hospitalier Universitaire de Rouen - Hôpital Charles Nicolle

Rouen, , France

Site Status

Centre Hospitalier Universitaire Saint Etienne Hopital Nord

Saint-Priest-en-Jarez, , France

Site Status

Hopital d instruction des armees sainte anne

Toulon, , France

Site Status

Universitaetsklinikum Frankfurt

Frankfurt am Main, , Germany

Site Status

Universitaetsmedizin Goettingen - Georg-August-Universitaet

Göttingen, , Germany

Site Status

TFS Trial Form Support GmbH

Hamburg, , Germany

Site Status

MensingDerma research GmbH

Hamburg, , Germany

Site Status

Hautaerzte Zentrum Hannover

Hanover, , Germany

Site Status

Medizinische Hochschule Hannover

Hanover, , Germany

Site Status

Universitaetsmedizin Mainz

Mainz, , Germany

Site Status

Beldio Research GmbH

Memmingen, , Germany

Site Status

Hautmedizin Saar

Merzing, , Germany

Site Status

Klinikum rechts der Isar der TUM

München, , Germany

Site Status

401 General Military Hospital Of Athens

Athens, , Greece

Site Status

Andreas Syngros Hospital Of Venereal And Dermatological Diseases

Athens, , Greece

Site Status

University General Hospital of Heraklion

Heraklion, , Greece

Site Status

General Hospital Of Nea Ionia Konstantopouleio Patision

Nea Ionia, , Greece

Site Status

Geniko Nosokomeio Peiraia Tzaneio

Piraeus, , Greece

Site Status

Ippokratio General Hospital of Thessaloniki

Thessaloniki, , Greece

Site Status

Trial Pharma Kft

Békéscsaba, , Hungary

Site Status

Csalogany Orvosi Kozpont

Budapest, , Hungary

Site Status

Clinexpert Kft

Budapest, , Hungary

Site Status

Obudai Egeszsegugyi Centrum Kft

Budapest, , Hungary

Site Status

Debreceni Egyetem Klinikai Kozpont

Debrecen, , Hungary

Site Status

Gyongyosi Bugat Pal Korhaz

Gyöngyös, , Hungary

Site Status

Somogy Varmegyei Kaposi Mor Oktato Korhaz

Kaposvár, , Hungary

Site Status

DermaMed Research Kft

Orosháza, , Hungary

Site Status

Allergo-Derm Bakos Kft

Szolnok, , Hungary

Site Status

Obudai Egeszsegugyi Centrum Kft

Zalaegerszeg, , Hungary

Site Status

Ospedale Policlinico San Martino IRCCS

Genova, , Italy

Site Status

Ospedale San Salvatore

LAquila, , Italy

Site Status

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Roma, , Italy

Site Status

IRCCS Istituto Clinico Humanitas

Rozzano MI, , Italy

Site Status

Fukui Dermatology Clinic

Nagoya, Aichi-ken, Japan

Site Status

Ekihigashi Dermatology Allergy Clinic

Fukuoka, Fukuoka, Japan

Site Status

Takagi Dermatological Clinic Branch

Obihiro-shi, Hokkaido, Japan

Site Status

Medical Corporation Kojinkai Sapporo Skin Clinic

Sapporo, Hokkaido, Japan

Site Status

Katahira Dermatology Urology Clinic

Kagoshima, Kagoshima-ken, Japan

Site Status

Kosugi Dermatology Clinic

Kawasaki-shi, Kanagawa, Japan

Site Status

Nomura Dermatology Clinic

Yokohama, Kanagawa, Japan

Site Status

Jouzan Hihuka Hinyoukika Clinic

Kumamoto, Kumamoto, Japan

Site Status

Suizenji Dermatology Clinic

Kumamoto, Kumamoto, Japan

Site Status

Yoshioka Dermatology Clinic

Neyagawa, Osaka, Japan

Site Status

JA Shizuoka Kohseiren Enshu Hospital

Hamamatsu, Shizuoka, Japan

Site Status

Mildix Skin Clinic

Adachi-ku, Tokyo, Japan

Site Status

Naoko Dermatology Clinic

Setagaya-ku, Tokyo, Japan

Site Status

NTT Medical Center Tokyo

Shinagawa-ku, Tokyo, Japan

Site Status

Yamate Dermatology Clinic

Shinjuku-ku, Tokyo, Japan

Site Status

Hospital Sultan Ismail

Johor Bahru, Johor, Malaysia

Site Status

Hospital Kuala Lumpur

Kuala Lumpur, Kuala Lumpur, Malaysia

Site Status

Pusat Perubatan Universiti Kebangsaan Malaysia

Kuala Lumpur, Kuala Lumpur, Malaysia

Site Status

University Malaya Medical Centre

Kuala Lumpur, Kuala Lumpur, Malaysia

Site Status

Hospital Raja Permaisuri Bainun

Ipoh, Perak, Malaysia

Site Status

Hospital Pulau Pinang

George Town, Pulau Pinang, Malaysia

Site Status

Queen Elizabeth Hospital

Kota Kinabalu, Sabah, Malaysia

Site Status

Bravis Ziekenhuis

Bergen op Zoom, , Netherlands

Site Status

Universitair Medisch Centrum Groningen

Groningen, , Netherlands

Site Status

Universitair Medisch Centrum Utrecht

Utrecht, , Netherlands

Site Status

Dermapolis Medical Dermatology Center dr n med Edyta Gebska

Chorzów, , Poland

Site Status

GynCentrum Spzoo NZOZ Holsamed - Oddzial Libero

Katowice, , Poland

Site Status

Specjalistyczny Gabinet Dermatologiczny Aplikacyjno-Badawczy Marek Brzewski Pawel Brzewski SpCywilna

Krakow, , Poland

Site Status

AppleTreeClinics Network Spzoo

Lodz, , Poland

Site Status

Ip Clinic Sp zoo

Lodz, , Poland

Site Status

Twoja Przychodnia Scm

Szczecin, , Poland

Site Status

DermMedica Spzoo Centrum Columbus

Wroclaw, , Poland

Site Status

Doctor Samuel Sanchez PSC

Caguas, , Puerto Rico

Site Status

Theramed Healthcare SRL

Brasov, , Romania

Site Status

Institutul Regional de Gastroenterologie si Hepatologie Prof Dr Octavian Fodor

Cluj-Napoca, , Romania

Site Status

Spitalul Clinic Judetean Mures

Târgu Mureş, , Romania

Site Status

National University Hospital

Singapore, , Singapore

Site Status

Singapore General Hospital

Singapore, , Singapore

Site Status

National Skin Centre

Singapore, , Singapore

Site Status

Maxderm, sro

Bardejov, , Slovakia

Site Status

Univerzitna nemocnica Bratislava - Nemocnica Stare Mesto

Bratislava, , Slovakia

Site Status

Fakultna nemocnica s poliklinikou JA Reimana Presov

Prešov, , Slovakia

Site Status

Sanare spol sro

Svidník, , Slovakia

Site Status

Univerzitetni klinicni center Ljubljana

Ljubljana, , Slovenia

Site Status

Univerzitetni Klinicni Center Maribor

Maribor, , Slovenia

Site Status

Hospital Universitario Basurto

Bilbao, Basque Country, Spain

Site Status

Hospital Clinic i Provincial de Barcelona

Barcelona, Catalonia, Spain

Site Status

Hospital General Universitario de Valencia

Valencia, Valencia, Spain

Site Status

Hospital Universitario 12 de Octubre

Madrid, , Spain

Site Status

Complexo Hospitalario Universitario de Pontevedra

Pontevedra, , Spain

Site Status

Inselspital Bern

Bern, , Switzerland

Site Status

Hopitaux Universitaires de Geneve

Geneva, , Switzerland

Site Status

Centre Hospitalier Universitaire Vaudois

Lausanne, , Switzerland

Site Status

Kantonsspital Sankt Gallen

Sankt Gallen, , Switzerland

Site Status

Universitaetsspital Zuerich

Zurich, , Switzerland

Site Status

Ankara Bilkent Sehir Hastanesi

Ankara, , Turkey (Türkiye)

Site Status

Istanbul Universitesi Istanbul Tip Fakultesi Hastanesi

Istanbul, , Turkey (Türkiye)

Site Status

Acibadem Altunizade Hastanesi

Istanbul, , Turkey (Türkiye)

Site Status

Marmara Universitesi Tip Fakultesi Hastanesi

Istanbul, , Turkey (Türkiye)

Site Status

Ondokuz Mayis Universitesi Tip Fakultesi Hastanesi

Samsun, , Turkey (Türkiye)

Site Status

Royal United Hospitals Bath NHS Foundation Trust

Bath, , United Kingdom

Site Status

Russells Hall Hospital

Dudley, , United Kingdom

Site Status

West Middlesex University Hospital

Isleworth, , United Kingdom

Site Status

The Royal Free Hospital

London, , United Kingdom

Site Status

Salford Care Organisation

Salford, , United Kingdom

Site Status

Accellacare Yorkshire

Shipley, , United Kingdom

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States Argentina Australia Austria Belgium Bulgaria Canada China France Germany Greece Hungary Italy Japan Malaysia Netherlands Poland Puerto Rico Romania Singapore Slovakia Slovenia Spain Switzerland Turkey (Türkiye) United Kingdom

References

Explore related publications, articles, or registry entries linked to this study.

Guttman-Yassky E, Simpson E, Bissonnette R, Eichenfield LF, Kabashima K, Luna PC, Hercogova JT, Spelman L, Worm M, Esfandiari E, Arai T, Mano H, Charuworn P, Wang A, Kricorian G. ROCKET: a phase 3 program evaluating the efficacy and safety of rocatinlimab in moderate-to-severe atopic dermatitis. Immunotherapy. 2025 Feb;17(2):83-94. doi: 10.1080/1750743X.2025.2464528. Epub 2025 Feb 26.

Reference Type BACKGROUND
PMID: 40012373 (View on PubMed)

Related Links

Access external resources that provide additional context or updates about the study.

http://www.amgentrials.com

AmgenTrials clinical trials website

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2022-501585-22-00

Identifier Type: REGISTRY

Identifier Source: secondary_id

20210144

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.